This was supported by a significantly greater decrease in the proliferative index and increase in the number of apoptotic cells in tumors treated with the two-drug combination, as highlighted by immunohistochemistry for Ki67 and Caspase-3, respectively (see representative tumor sections from each treatment cohort and quantitative results in Figure 6C,D). This evidence concerns the gene CASP3 and neoplasm.